CLINICAL_TRIALS
research
· 2026-02-17
Clinical Trial Update: Imatinib TDM in GIST [Phase 2]
Summary
A Phase 2 clinical trial is recruiting to evaluate therapeutic drug monitoring of imatinib in patients with gastrointestinal stromal tumors.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Reema A. Patel | Conditions: Gastrointestinal Stromal Tumors | Phase 2 | Status: RECRUITING